Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Fred Hutchinson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
NRG Oncology
City of Hope Medical Center
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center